Treatment of Pleurisy in Familial Mediterranean Fever

Pleurisy in the setting of Familial Mediterranean Fever (FMF) is a specific clinical presentation driven by the underlying autoinflammatory condition. Managing pleurisy here requires an approach aligned with FMF treatment rather than a generic pleurisy protocol.

Clinical Scenario

This protocol is for patients with a confirmed diagnosis of Familial Mediterranean Fever who present with pleurisy. The recurring inflammatory nature of FMF is the central factor that shapes the treatment choice in this context.

Treatment Approach — Partial Overview

The mainstay of treatment in this scenario is colchicine, an established oral agent with a recognised role in Familial Mediterranean Fever. The complete dosing regimen and full clinical protocol are available below.

Instant Access to Structured Evidence-Based Regimens

References

Colchicine (1.2 to 2.0 mg orally once per day, or twice per day in a divided dose) is the mainstay of treatment for familial Mediterranean fever.

View source ↗